Flint Congressman Wants Probe After Lead Treatment Drug Price Hike

Cookie Control

This site uses cookies to store information on your computer.

Some cookies on this site are essential, and the site won't work as expected without them. These cookies are set when you submit a form, login or interact with the site by doing something that goes beyond clicking on simple links.

We also use some non-essential cookies to anonymously track visitors or enhance your experience of the site. If you're not happy with this, we won't set these cookies but some nice features of the site may be unavailable.

By using our site you accept the terms of our Privacy Policy.

Cookies are on

(One cookie will be set to store your preference)

Do not ask me again
(Ticking this sets a cookie to hide this popup if you then hit close. This will not store any personal information)

Flint Congressman Wants Probe After Lead Treatment Drug Price Hike

"FLINT, MI – Rep. Dan Kildee has asked Congressional leaders to launch an investigation into a pharmaceutical company accused of raising prices of its lead treatment drug in the wake of Flint's lead water crisis receiving international attention.

However, the company claims the drug wouldn't be appropriate for treating those afflicted during the city's water crisis.

Kildee, D-Flint Twp., sent the letter Tuesday, Nov. 1, asking congressional leaders to investigate Valeant Pharmaceuticals' price hike on Calcium Disodium Versenate."

Gary Ridley reports for the Flint Journal November 1, 2016.

Chemicals

Economy & Business

Environmental Health

Environmental Politics

Source: Flint Journal, 11/02/2016

Cookie Control

Flint Congressman Wants Probe After Lead Treatment Drug Price Hike

Search for Headlines

Browse Headlines